A Novel Sarcopenia Screening Score Based on Thyroid Function Parameters in Euthyroid Middle‐Aged and Elderly Chinese Adults
International Journal of Endocrinology · 2026-01 · 2026 (1)
DOI: 10.1155/ije/1577695 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Endocrinology, online erschienen am 24.06.2026. Verfasst von Fei Ding und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China, scu.edu.cn. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Department of Science and Technology of Sichuan Province.
Abstract (Originalsprache)
Background
This research aims to develop an alternative sarcopenia screening score based on thyroid hormone function parameters, intended for screening and validating the probability of having sarcopenia among middle‐aged and elderly participants with normal thyroid function tests in China.
Methods
This multicenter, cross‐sectional study assessed the prevalence of sarcopenia among 3,858 thyroid‐healthy Chinese adults across hospitals in western China hospitals. Participants were randomized to exploratory and validation cohorts. After applying Lasso to select variables, multivariate logistic regression analysis was conducted. We developed a novel sarcopenia screening score from exploratory data, subsequently validating it internally across both cohorts.
Results
The new sarcopenia screening score comprises five variables: age, body mass index (BMI), calf circumference (CC), aspartate aminotransferase/alanine aminotransferase ratio (AST/ALT), and free T4 (FT4), with a scoring range of 0–14. The area under the receiver operating characteristic (ROC) curve for screening for sarcopenia was 0.845 (95% CI: 0.831–0.859) in the exploratory group and 0.854 (95% CI: 0.831–0.874) in the validation group. At the optimal cutoff of 3, the sensitivity and specificity were 78.3% and 75.1%, respectively, in the exploratory cohort; in the validation cohort, with a cutoff of 4, sensitivity and specificity were 68.4% and 87.0%. The Brier score was 0.092 in the exploratory cohort and 0.068 in the validation cohort, confirming satisfactory calibration.
Conclusion
The newly developed sarcopenia screening score shows promise as a practical tool for identifying sarcopenia in middle‐aged and elderly participants with normal thyroid function tests in China.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China, scu.edu.cn.
- Department of Laboratory Medicine, Clinical Laboratory Medicine Research Center Chengdu, Chengdu, Sichuan, China, scu.edu.cn.
- West China Hospital, Sichuan Clinical Research Center for Laboratory Medicine Chengdu, Sichuan University, Chengdu, Sichuan, China, scu.edu.cn.
- Department of Geriatrics and National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, China, scu.edu.cn.
ORCID-Profile: Fei Ding, Jirong Yue, Yong He
Förderung
- National Key Research and Development Program of China
- Department of Science and Technology of Sichuan Province
Zitieren
APA
Ding, F., Yue, J., & He, Y. (2026). A Novel Sarcopenia Screening Score Based on Thyroid Function Parameters in Euthyroid Middle‐Aged and Elderly Chinese Adults. International Journal of Endocrinology, 2026(1). https://doi.org/10.1155/ije/1577695
Vancouver
Ding F, Yue J, He Y. A Novel Sarcopenia Screening Score Based on Thyroid Function Parameters in Euthyroid Middle‐Aged and Elderly Chinese Adults. International Journal of Endocrinology. 2026;2026(1). doi:10.1155/ije/1577695
BibTeX
@article{Ding2026,
author = {Ding, Fei and Yue, Jirong and He, Yong},
title = {A Novel Sarcopenia Screening Score Based on Thyroid Function Parameters in Euthyroid Middle‐Aged and Elderly Chinese Adults},
journal = {International Journal of Endocrinology},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/ije/1577695}
}
EUVIMED